You’ve probably taken Tylenol, aka acetaminophen, at some point, maybe for a headache, a backache, or even a fever. It’s one of the most common over-the-counter drugs in the world. But, despite being around for over a century, we’ve never understood how it works. That’s right, this little white pill that’s been living in your medicine cabinet has been something of a scientific mystery.
But now, a groundbreaking 2025 study may have finally connected the dots. And the answer has something to do with the same biological system that cannabis targets: your endocannabinoid system. Here’s more on how Tylenol works and what it can teach us about medical marijuana.
The Surprising Way Tylenol Uses Your Cannabinoid System to Relieve Pain
Let’s start with the basics. Inside your body, you have a natural system called the endocannabinoid system (ECS). It helps regulate things like mood, pain, appetite, and memory. The ECS includes chemicals your body makes, like 2-AG and anandamide, and receptors such as CB1, primarily in your brain and nervous system. THC, the active compound in cannabis, binds to these receptors, which is how marijuana alters your perception and can relieve pain.
Now here’s the twist: the study found that acetaminophen (Tylenol) appears to relieve pain not by reducing inflammation, like ibuprofen, and not just by dulling your brain’s perception of pain, but by subtly tinkering with the ECS.
Specifically, it blocks an enzyme called DAGLα, which your brain uses to produce 2-AG, one of the main endocannabinoids that activate CB1 receptors. When acetaminophen blocks DAGLα, less 2-AG is made, and as a result, there’s less CB1 activation. Strange as it may sound, this reduction in CB1 activity might help reduce pain.
Why Less Cannabinoid Activation Can Sometimes Mean Less Pain
If you’re familiar with cannabis, you might think CB1 activation is always a good thing when it comes to pain relief. After all, THC activates CB1 and helps many people manage chronic pain. But it turns out, the endocannabinoid system is more complicated than a simple on/off switch. It depends on which parts of the brain or nervous system are involved. In some circuits, activating CB1 receptors relieves pain. But in others? It might do the opposite—enhance pain or make it worse.
The researchers found that inhibiting DAGLα and lowering 2-AG production reduces CB1 activity in a specific circuit that actually allows pain signals to pass through. Think of it like flipping off a light switch that was accidentally keeping a door open for pain signals. The door closes once the switch is off, and the pain lessens.
This explains why acetaminophen only reduced pain in experiments with mice if the animals had functional CB1 receptors. In mice genetically modified to lack CB1 receptors, Tylenol had no effect. Even more interesting, a separate drug that inhibits DAGLα also worked, but only when CB1 was present. It’s a tightly linked process.
What Tylenol’s Secret Says About Cannabis and Pain
This study does more than just explain how Tylenol works. It also shines a new light on how you might think about medical cannabis. The big takeaway? Cannabinoid therapy isn’t just about flooding your system with THC or CBD to activate everything. Sometimes, dialing down specific parts of the endocannabinoid system could be more effective than turning it all up.
In other words, Tylenol may offer pain relief by reducing endocannabinoid activity, not enhancing it. That sounds counterintuitive until you realize that some cannabinoid activity can be pain-permissive rather than pain-blocking.
The ECS is circuit-specific, meaning CB1 activity in one part of your nervous system might help, while in another part, it could hurt. This adds weight to what many patients already feel—that cannabis works differently for everyone and that strain selection, dosage, and cannabinoid profile truly matter.
So, what does Tylenol teach us? It teaches us that the ECS is a delicate, dynamic system, and manipulating it isn’t always about boosting it. Sometimes, strategically muting it is what brings relief.
The Research That Proves Tylenol’s Cannabinoid Connection
To confirm their theory, researchers went deep. They used autaptic hippocampal neurons, special cells that can talk to themselves, which is perfect for studying signaling in isolation.
They found that acetaminophen significantly inhibited DSE (depolarization-induced suppression of excitation) in these cells, a process that depends on 2-AG and CB1 signaling.
The more acetaminophen they added, the less DSE they saw. That meant less 2-AG was being made, and less CB1 activity occurred.
They then moved to cell cultures and used assays to measure DAGLα activity directly. Again, acetaminophen significantly reduced enzyme activity by nearly 45% in some tests. But it didn’t touch DAGLβ, its molecular cousin.
The researchers also tried exposing cells to AM404, a metabolite of acetaminophen that earlier studies thought might activate CB1 indirectly. However, AM404 had no significant effect on cannabinoid signaling in their model.
Finally, behavioral tests showed that mice given either acetaminophen or a DAGLα inhibitor responded to heat pain significantly slower (i.e., had pain relief). But only if they had working CB1 receptors. In CB1-deficient mice, the same treatments did nothing. That kind of precision adds serious weight to the findings.
The Bigger Picture: What You Should Take Away
So, where does this leave you? If you’re a patient, a caregiver, or just someone curious about how cannabis and pain interact, this study gives you a whole new framework for thinking. It tells you that pain management through the endocannabinoid system is not a one-size-fits-all.
It tells you that some parts of the ECS may promote pain and that effective therapies might come not just from mimicking cannabinoids, but from modulating the enzymes and pathways behind them.
It also suggests a potential future where drugs like acetaminophen and cannabinoid-based treatments aren’t seen as opposites, but rather as different ways of tapping into the same biological toolkit.
With more research, we might develop targeted DAGLα inhibitors or refined cannabinoid blends that deliver powerful, tailored pain relief, without the risks of opioids or the trial-and-error of strain hunting.
Final Thoughts: When Pain Relief Meets Biology
It’s not every day that a 150-year-old drug surprises the medical community. But that’s precisely what Tylenol has done. By stepping into the world of cannabinoids, not through buzzwords or marketing hype, but through detailed neuroscience, acetaminophen has reopened the conversation about how we treat pain and how cannabis fits into that puzzle.
You might never look at Tylenol or your endocannabinoid system the same way again. And that’s a good thing. Understanding how your body manages pain and how to help it do that better is the first step toward smarter, more effective healing.
Discover Natural Pain Relief with DocMJ
Ready to explore how medical cannabis could work with your body’s systems, just like Tylenol does? At DocMJ, our certified physicians are here to help you find a personalized path to relief through safe, legal medical marijuana. Book your consultation today and take the first step toward smarter, science-backed wellness.
Dr. Rothman is a diplomate of the American Board of Obstetrics and Gynecology. He has received multiple special awards and recognitions, including Physician of the Year, from the Pinellas County Medical Association (2014 – 2015) and the President’s Service Award from the Pinellas County Medical Society.
He attended medical school at State University of New York Upstate Medical Center in Syracuse, New York, where he also completed his Obstetrics and Gynecology residency. In addition to practicing medicine, Dr. Rothman’s professional career includes being an Assistant Professor at the University of South Florida and Clinical Instructor at the University of Tampa’s College of Nursing.
Dr. Rothman received his Florida Medical Marijuana Physicians Certification in 2016 and was one of the first recommending physicians through DocMJ in the state and is loved by many of those early patients today.